Provided by Tiger Fintech (Singapore) Pte. Ltd.

Shuttle Pharmaceuticals Inc

3.91
-0.0600-1.51%
Post-market: 3.88-0.0300-0.77%16:54 EDT
Volume:60.32K
Turnover:233.43K
Market Cap:1.72M
PE:-1.18
High:3.98
Open:3.90
Low:3.72
Close:3.97
Loading ...

Shuttle Pharmaceuticals Announces Closing of $4.25 Million Private Placement Priced at-the-Market

THOMSON REUTERS
·
25 Jun

Press Release: Shuttle Pharmaceuticals Announces Closing of $4.25 Million Private Placement Priced At-the-Market

Dow Jones
·
25 Jun

Shuttle Pharmaceuticals Announces Pricing of $4.25 Million Private Placement Priced at-the-Market

THOMSON REUTERS
·
21 Jun

Shuttle Pharmaceuticals Holdings Inc trading halted, news pending

TIPRANKS
·
14 Jun

Shuttle Pharmaceuticals says reverse stock split to become effective June 16

TIPRANKS
·
13 Jun

Shuttle Pharma Announces Reverse Stock Split Will Become Effective on June 16, 2025, at 12:01 a.m., Eastern Time

THOMSON REUTERS
·
13 Jun

Shuttle Pharmaceuticals announces 25-for-1 proposed reverse stock split

TIPRANKS
·
12 Jun

Shuttle Pharmaceuticals Holdings Inc - Pharma Board Approves 25-for-1 Reverse Stock Split

THOMSON REUTERS
·
12 Jun

Shuttle Pharma Announces Proposed Reverse Stock Split as Part of Strategic Nasdaq Compliance Initiative

THOMSON REUTERS
·
12 Jun

Shuttle Pharmaceuticals appoints George Scorsis as chairman

TIPRANKS
·
05 Jun

Shuttle Pharma Appoints George Scorsis Chairman of the Board of Directors

THOMSON REUTERS
·
05 Jun

Press Release: Shuttle Pharma Appoints George Scorsis Chairman of the Board of Directors

Dow Jones
·
05 Jun

Shuttle Pharmaceuticals Holdings Inc - Implements 70% Salary Reduction for Executives - SEC Filing

THOMSON REUTERS
·
28 May

Shuttle Pharmaceuticals Implements 70% Salary Reduction for Executives, Defers CFO Compensation

Reuters
·
28 May

Shuttle Pharma Provides Corporate Update

THOMSON REUTERS
·
16 May

Shuttle Pharma FDA Orphan-Drug Nears Patient Enrollment Milestone for Phase 2 Clinical Trial

THOMSON REUTERS
·
09 May

Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

GlobeNewswire
·
22 Apr

Shuttle Pharmaceuticals Files Provisional US Patent to Treat Prostrate Cancer

MT Newswires Live
·
11 Apr

BRIEF-Shuttle Pharmaceuticals Files Provisional Patent Application For PSMA Ligand Conjugates To Treat Prostate Cancer

Reuters
·
11 Apr

Shuttle Pharmaceuticals- Files Provisional Patent Application for Psma Ligand Conjugates to Treat Prostate Cancer

THOMSON REUTERS
·
11 Apr